Evidence map›Paper›PMID 31681243›Full record

ArticleFrontiers in microbiology2019

Fungal Growth in Batch Culture - What We Could Benefit If We Start Looking Closer.

Pamela Vrabl, Christoph W Schinagl, Desirée J Artmann, Benedikt Heiss, Wolfgang Burgstaller

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Extracellular Phosphate Availability ImpactsJournal of fungi (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Journal of the Royal Society, Interface · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Solid-State Fermentation ofJournal of agricultural and food chemistry · 2023
    Article
  19. Article
  20. Characterization of the Growth and Morphology of a BSL-2Journal of fungi (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pamela VrablInstitute of Microbiology, University of Innsbruck, Innsbruck, Austria.
Christoph W SchinaglInstitute of Microbiology, University of Innsbruck, Innsbruck, Austria.
Desirée J ArtmannInstitute of Microbiology, University of Innsbruck, Innsbruck, Austria.
Benedikt HeissInstitute of Microbiology, University of Innsbruck, Innsbruck, Austria.
Wolfgang BurgstallerInstitute of Microbiology, University of Innsbruck, Innsbruck, Austria.

Funding

Austrian Science Fund FWF P 22220Austrian Science Fund FWF T 862
6 · The paper itself

Abstract

Since filamentous fungi rapidly adjust their metabolic properties to environmental changes, a rigorous standardization and characterization of cultivation conditions is necessary to obtain meaningful and reproducible results. In batch cultures, which are commonly characterized according to the classical growth curve in textbooks (i.e., lag, exponential, stationary, and declining phase), this is of special difficulty. Although various studies in literature report atypically shaped growth curves of filamentous fungi in batch culture, systematic investigations on this topic are scarce and deviations are barely mentioned in textbooks. Summarizing approximately a decade of observations of growth characteristics from bioreactor batch grown filamentous fungi - in particular two strains (CBS123.823 and CBS123.824) of

Indexed as

alternative growth curve schemeAspergillus nidulansbioreactor batch cultureexperimental standardizationgrowth phasesPenicillium ochrochloronrespirometryTrichoderma harzianum

Identifiers

PMID31681243
PMCPMC6805767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.